G H Reaman

1.2k total citations
17 papers, 915 citations indexed

About

G H Reaman is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, G H Reaman has authored 17 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in G H Reaman's work include Acute Lymphoblastic Leukemia research (11 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Acute Myeloid Leukemia Research (4 papers). G H Reaman is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Acute Myeloid Leukemia Research (4 papers). G H Reaman collaborates with scholars based in United States. G H Reaman's co-authors include Harland N. Sather, W. Archie Bleyer, Paul S. Gaynon, J Z Finklestein, Peter G. Steinherz, P. Steinherz, H N Sather, Paul M. Zeltzer, Beatriz E. Amendola and D Hammond and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

G H Reaman

17 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G H Reaman United States 13 503 378 310 160 134 17 915
Marit Hellebostad Norway 16 475 0.9× 413 1.1× 389 1.3× 160 1.0× 84 0.6× 37 929
B Smedmyr Sweden 20 370 0.7× 684 1.8× 278 0.9× 280 1.8× 189 1.4× 38 1.2k
Lawrence J. Wolff United States 12 494 1.0× 282 0.7× 327 1.1× 89 0.6× 45 0.3× 23 777
Roberto Rivera‐Luna Mexico 16 326 0.6× 141 0.4× 280 0.9× 176 1.1× 46 0.3× 67 808
Margaret Masterson United States 15 263 0.5× 600 1.6× 137 0.4× 139 0.9× 55 0.4× 41 930
Thuan Chong Quah Singapore 15 474 0.9× 171 0.5× 452 1.5× 193 1.2× 31 0.2× 56 874
Christopher Fraser Australia 13 194 0.4× 418 1.1× 154 0.5× 261 1.6× 86 0.6× 33 799
Asim Belgaumi Saudi Arabia 18 293 0.6× 151 0.4× 244 0.8× 305 1.9× 70 0.5× 63 959
Michael Steinbuch United States 14 218 0.4× 613 1.6× 200 0.6× 288 1.8× 280 2.1× 24 1.3k
Hassan El Solh Saudi Arabia 15 200 0.4× 179 0.5× 194 0.6× 135 0.8× 24 0.2× 33 641

Countries citing papers authored by G H Reaman

Since Specialization
Citations

This map shows the geographic impact of G H Reaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G H Reaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G H Reaman more than expected).

Fields of papers citing papers by G H Reaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G H Reaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G H Reaman. The network helps show where G H Reaman may publish in the future.

Co-authorship network of co-authors of G H Reaman

This figure shows the co-authorship network connecting the top 25 collaborators of G H Reaman. A scholar is included among the top collaborators of G H Reaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G H Reaman. G H Reaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Wen, Wanqing, Xiao‐Ou Shu, M. Steinbuch, et al.. (2000). Paternal Military Service and Risk for Childhood Leukemia in Offspring. American Journal of Epidemiology. 151(3). 231–240. 36 indexed citations
3.
Avramis, Vassilios I., Susan R. Wiersma, Mark Krailo, et al.. (1998). Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.. PubMed. 4(1). 45–52. 38 indexed citations
4.
Uckun, Fatih M., P S Gaynon, Martha G. Sensel, et al.. (1997). Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.. Journal of Clinical Oncology. 15(6). 2214–2221. 81 indexed citations
5.
Lal, Binesh, Agostino Riva, J A Johnston, et al.. (1995). Regulation of JAK3 expression and activation in human B cells and B cell malignancies. The Journal of Immunology. 155(11). 5220–5226. 67 indexed citations
6.
Merritt, William D., et al.. (1994). Increased GD3 ganglioside in plasma of children with T-cell acute lymphoblastic leukemia.. PubMed. 8(5). 816–22. 19 indexed citations
7.
Gaynon, Paul S., Peter G. Steinherz, W. Archie Bleyer, et al.. (1993). Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106.. Journal of Clinical Oncology. 11(11). 2234–2242. 94 indexed citations
8.
Patel, Ravi, Edward M. Newman, Judith K. Sato, et al.. (1991). Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study Group.. PubMed. 51(18). 4871–5. 11 indexed citations
9.
Bleyer, W. Archie, et al.. (1988). INTENSIVE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AND UNFAVOURABLE PRESENTING FEATURES. The Lancet. 332(8617). 921–924. 100 indexed citations
10.
Steinherz, Peter G., Paul S. Gaynon, J Z Finklestein, et al.. (1988). The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia.. Journal of Clinical Oncology. 6(9). 1425–1432. 51 indexed citations
11.
Gaynon, P S, P. Steinherz, G H Reaman, et al.. (1987). Strategies for the Treatment of Children with Acute Lymphoblastic Leukemia and Unfavorable Presenting Features. Hämatologie und Bluttransfusion. 30. 167–172. 11 indexed citations
13.
Reaman, G H, Paul M. Zeltzer, W. Archie Bleyer, et al.. (1985). Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group.. Journal of Clinical Oncology. 3(11). 1513–1521. 130 indexed citations
14.
Balis, Frank M., J. Miser, James H. Feusner, et al.. (1985). Altered central nervous system pharmacology of methotrexate in childhood leukemia: another sign of meningeal relapse.. Journal of Clinical Oncology. 3(1). 19–24. 20 indexed citations
15.
Reaman, G H, et al.. (1983). ALTERED DISTRIBUTION OF T-LYMPHOCYTE SUBPOPULATIONS IN CHILDREN AND ADOLESCENTS WITH HAEMOPHILIA. The Lancet. 321(8323). 503–505. 70 indexed citations
16.
Reaman, G H, DG Poplack, S Broder, & Werner J. Pichler. (1980). Fc receptors on human T lymphocytes. V: Effects of colchicine and cytochalasin B on Fc receptor expression.. The Journal of Immunology. 125(5). 2215–2219. 8 indexed citations
17.
Gunn, Tania R., G H Reaman, E.W. Outerbridge, & Eleanor Colle. (1978). Peripheral total parenteral nutrition for premature infants with the respiratory distress syndrome: A controlled study. The Journal of Pediatrics. 92(4). 608–613. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026